Systemic Treatment of Non-Small Cell Lung Cancer
Edited by Giuseppe Giaccone
Author Information
Giuseppe Giaccone, M.D., Ph.D. is an internationally recognized expert in the field of lung cancer and developmental therapeutics. Dr. Giaccone received his M.D. cum laude from the University of Torino Medical School in 1980, followed by training in clinical oncology and internal medicine, which he completed at the University of Torino in 1988. He spent the next two years in the NCI's Medical Oncology Branch. Following his training at the NCI, Dr. Giaccone received his Ph.D. from the Free University Medical Center in Amsterdam, The Netherlands. He then served as a senior medical oncologist at the Medical Center from 1990 to 2000, when he was appointed Professor of Medical Oncology. Dr. Giaccone became Head of the Center's Department of Medical Oncology in 2003. Dr. Giaccone has published more than 400 peer-reviewed papers and contributed to more than 30 book chapters. He has also played a major role in the European Organization for Research and Treatment of Cancer (EORTC).
Contributors:
Paul Baas, Netherlands Cancer Institute, Amsterdam, Netherlands
Benjamin Besse, Department of Medicine, Institut Gustave Roussy, Villejuif, France
Hak Choy, Radiation Oncology, Moncrief Building, Dallas, TX, USA
Sofie De Craene Department of Respiratory Medicine & Thoracic Oncology, University Hospital, Ghent, Belgium
Margaret Edwards, Radiation Oncology, Moncrief Building, Dallas, TX, USA
Adi F. Gazdar, Hamon Center for Therapeutic Oncology Research, Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX ,USA
Giuseppe Giaccone, Medical Oncology Branch, National Cancer Institute, Bethesda, MD, USA
Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA, USA
Jill E. Larsen, Hamon Center for Therapeutic Oncology Research, Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA
John D. Minna, Hamon Center for Therapeutic Oncology Research, Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA
Taylor M. Ortiz, Dana-Farber Cancer Institute, Boston, MA, USA
Arun Rajan, Medical Oncology Branch, National Cancer Institute, Bethesda, MD, USA
Frances A. Shepherd, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada
Jean Charles Soria, Department of Medicine, Institut Gustave Roussy, Villejuif, France
Kurt G Tournoy, Department of Respiratory Medicine & Thoracic Oncology, University Hospital; Lung Oncological Network Ghent (LONG), Ghent, Belgium
Wilma Uyterlinde, Netherlands Cancer Institute, Amsterdam, Netherlands
Jan P. van Meerbeeck, Department of Respiratory Medicine & Thoracic Oncology, University Hospital; Lung Oncological Network Ghent (LONG), Ghent, Belgium
Paul Wheatley-Price, Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, Ontario, Canada